Last updated: 5 months ago
SciSparc Ltd. December 2024 Report: Key Insights on Pharmaceutical Spin-Off
Explore SciSparc Ltd.'s December 2024 Form 6-K report detailing the strategic spin-off of its pharmaceutical portfolio, signed by CEO Oz Adler. Essential for investors!